(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVREEO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AVREEO

ST13

US500000079261084

Class

5, 10

Filing

79261084

Registration

6109859

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

07/29/2025

Trademark type

Word

Nice classes

5, 10

Filing date

04/16/2019

Registration date

07/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/28/2020

Last transaction

07/29/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

MARCY, AMY

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine and the musculo-skeletal system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology and in rheumatology; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; all the aforesaid goods to be available upon prescription onlynot for over-the-counter salenone of them for topical administration

Class 10

Medical devicesmedical devices for diagnosing or treating respiratory conditionsmedical devices for facilitating the inhalation of pharmaceutical preparations; injection devices for medical useinjection devices for pharmaceuticalsinjection devices for administering drugs; autoinjectors in the nature of injection devices for the administration of pharmaceutical preparations

Publications

History of USPTO decisions and trademark events.

40 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/28/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/05/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/16/2020

FIMP

FINAL DISPOSITION PROCESSED

11/16/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/28/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

07/28/2020

CHPB

POST PUBLICATION AMENDMENT - ENTERED

06/23/2020

APET

ASSIGNED TO PETITION STAFF

06/17/2020

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

06/04/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

05/19/2020

CHPB

POST PUBLICATION AMENDMENT - ENTERED

03/25/2020

APET

ASSIGNED TO PETITION STAFF

03/23/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/18/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/18/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/18/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

02/18/2020

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

11/26/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/05/2019

PUBO

PUBLISHED FOR OPPOSITION

11/05/2019

GPNX

NOTIFICATION PROCESSED BY IB

11/01/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/16/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/16/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/16/2019

ALIE

ASSIGNED TO LIE

09/30/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/23/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/26/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/26/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/26/2019

RFNT

REFUSAL PROCESSED BY IB

08/23/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/08/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/08/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/03/2019

RFRR

REFUSAL PROCESSED BY MPU

08/03/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/16/2019

CNRT

NON-FINAL ACTION WRITTEN

07/15/2019

MAFR

APPLICATION FILING RECEIPT MAILED

07/10/2019

DOCK

ASSIGNED TO EXAMINER

07/06/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/06/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/01/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/20/2019

Continuous trademark protection

Get notified about every new filing that threatens AVREEO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.